WG
William Garrett Gray
Chief Financial Officer

William Garrett Gray insider trades: Checkpoint Therapeutics (CKPT) stock sales

Chief Financial Officer, Checkpoint Therapeutics Last trade Apr 1, 2025 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2020
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where William reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 1, 2025CKPT↓ Sell$50K
Feb 6, 2025CKPT↓ Sell$272K
Dec 18, 2024CKPT↓ Sell$1.1M
Jun 26, 2024CKPT↓ Sell$27K
Feb 28, 2024CKPT↓ Sell$4K
Feb 1, 2024CKPT↓ Sell$8K
Mar 2, 2023CKPT↓ Sell$27K
Feb 1, 2023CKPT↓ Sell$15K
Jan 10, 2023CKPT↓ Sell$13K
Mar 10, 2022CKPT↓ Sell$72K
Feb 1, 2022CKPT↓ Sell$93K
Feb 4, 2021CKPT↓ Sell$96K
Dec 22, 2020CKPT↓ Sell$7K
May 21, 2020CKPT↓ Sell$34K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About William Garrett Gray's insider trades

William Garrett Gray is Chief Financial Officer at Checkpoint Therapeutics (CKPT). Since May 21, 2020, William has reported no open-market purchases and 14 sales worth $1.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (10 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CKPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.